Formulations for non-viral in vivo transfection in the lungs
US6022737A · kind A · utility
43Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 1995 |
| Grant date | Feb 8, 2000 |
| Priority date | — |
| Expiry date | Nov 2, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/924
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Formulations useful in improving non-viral in vivo transfection of DNA in the lungs are provided. Formulations which comprise DNA with various additives are prepared and delivered to the lungs resulting in production of a transcription product.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.